Bengt Åke Julander

Bengt Åke Julander

Fondateur chez LINC AB

Fortune : 257 M $ au 31/05/2026

73 ans
Health Technology
Finance
Health Services

Profil

Bengt Åke Julander founded Calliditas Therapeutics AB in 2004, where he worked as Independent Non-Executive Director from 2004 to 2020 and Linc AB in 1991, where he is working as Chairman from 1991.
Mr. Julander also currently works at Knil AB, as Chairman, Livland Skog AB, as Chairman, Cronhamn Invest AB, as Chairman, Part Production AB, as Chairman, Bringwell AB, as Director from 2016, Unimedic AB, as Director, nWise AB, as Director, Specialistgruppen Eriksbergskliniken AB, as Director from 2010, Ergobe Pharma AB, as Director, Vetgross AB, as Director, Swevet AB, as Director, Swevet Holding AB, as Director, Proequo AB, as Director, Nefecon AB, as Director, Busulipo AB, as Director, Linc International AB, as Deputy Director, Linc Trade AB, as Deputy Director, Algarvefastigheter AB, as Deputy Director, KV Eldstaden i Bromma AB, as Deputy Director, Pharmalink Nordic AB, as Director, Eriksbergskliniken Gam AB, as Deputy Director, Korkyl Holding AB, as Deputy Director, Linc Global AB, as Deputy Director, and Reison Medical AB, as Director.
Mr. Julander also formerly worked at Linc AB (Old), as Chief Executive Officer & Director, Stille AB, as Chairman from 2011 to 2012, MedCap AB, as Chairman & Director-Investor Relations from 2007 to 2012, Alimenta Medical AB, as Chairman, Antibody Therapeutics, Inc., as Chairman, Medivir AB, as Independent Director from 2017 to 2021, Anmedic AB, as Director, Eriksbergskliniken AB, as Director, and Sedana Medical AB, as Independent Director.
Mr. Julander received his graduate degree from the University of Uppsala.

Détentions connues dans des sociétés publiques

SociétéDateNombre d'actionsValorisationDate de valorisation
LINC AB
55,92%
31/12/2025 32 383 599 ( 55,92% ) 257 M $ 31/05/2026

Postes actifs de Bengt Åke Julander

SociétésPosteDébut
BRINGWELL PUBL AB Directeur/Membre du Conseil 28/04/2016
LINC AB Fondateur 01/01/1991
Président -
Eriksbergskliniken Gam AB
Corporate Officer/Principal -
Directeur/Membre du Conseil -
Linc Global AB
Corporate Officer/Principal -
Corporate Officer/Principal -
Linc Trade AB
Directeur/Membre du Conseil -
Directeur/Membre du Conseil -
░░░░ ░░░░░░░░░░ ░░ ░░░░░░░░░░ -
░░░░░░ ░░░░░░░ ░░ ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ -

Anciens postes connus de Bengt Åke Julander

SociétésPosteFin
░░░░░░░ ░░ ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ ░░░░░░░░░░
░░░░░░░░░░ ░░░░░░░░░░░░ ░░ ░░░░░░░░░ ░░░░░░░░░░
░░ ░░░░░░░░░ ░ ░░░░░░ ░░ ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ ░░░░░░░░░░
░░░░░░░░ ░░░░░░░░░░░░░ ░░░░ ░░░░░░░░░░ -
░░░░░░░░░░░░░░░░░░ ░░ ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ -
Voir l'expérience en détail de Bengt Åke Julander

Formation de Bengt Åke Julander

Expériences
Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Relations

37

Relations au 1er degré

36

Entreprises liées au 1er degré

Homme

Femme

Administrateurs

Exécutifs

Sociétés liées

Entreprise privées36

Health Technology

Consumer Non-Durables

Health Technology

Health Technology

Consumer Services

Health Technology

Health Technology

Finance

Anmedic AB

Technology Services

Specialistgruppen Eriksbergskliniken AB

Health Services

Distribution Services

Health Services

Finance

Vetgross AB

Swevet AB

Miscellaneous

Health Technology

Commercial Services

Proequo AB

Health Technology

Health Technology

Finance

Linc Trade AB

Algarvefastigheter AB

Finance

Finance

Cronhamn Invest AB

Pharmalink Nordic AB

Eriksbergskliniken Gam AB

Korkyl Holding AB

Linc Global AB

Finance

Health Technology

Antibody Therapeutics, Inc.

  1. Bourse
  2. Insiders
  3. Bengt Åke Julander
-40% : Prolongation exceptionnelle ➤➤➤➤
j
:
:
PROFITEZ-EN MAINTENANT